Genmab — Oktober 2024
-
Mon ikke J&J appellerer dommen. Hvis dommen stadfæstes betyder det vel, at biosimilære kopier kan udfordre DARA allerede efter 2029 i EU. Hvis en lignende dom måtte finde sted i USA forsvinder alle J&J's eventuelle spekulative incitament til at takke "nej" til at gå videre med SuperData vel? Eller overser jeg noget?
-
-
Godmorgen

Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind